In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick), against human lymphatic filarial parasite Brugia malayi: antifilarial activity of H. exigua.
The present study reports on the antifilarial activity of a marine sponge Haliclona exigua (phylum Porifera). The crude methanol extract and n-butanol-soluble fraction killed adult Brugia malayi at 31.25-microg/ml concentration (both in motility and 3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide assay) while the chloroform fraction was lethal at a lower concentration of 15.6 microg/ml. The activity could be located in a single molecule araguspongin C which brought about mortality of worm at 15.6 microg/ml. In vivo evaluation of the crude extract (5 x 500 mg/kg, orally) and the chloroform fraction (5 x 250 mg/kg, orally) in B. malayi-infected rodent host, Mastomys coucha, did not show any significant microfilaricidal actions; however, microfilarial densities in both the treated groups were significantly much lower than those of untreated group in contrast to standard filaricide diethylcarbamazine which exerted 79% microfilaricidal action on day 8 of treatment. Both these extracts also demonstrated adulticidal (macrofilaricidal) activity which was more pronounced in the chloroform fraction (50.2%). In addition, there was moderate adverse effect on the reproductive potential of female worms (crude extract 46.5%; chloroform 58.6%). The findings suggest that the marine sponge H. exigua possesses adulticidal and embryostatic action against human lymphatic filarial parasite B. malayi in experimental rodent model and this activity could be attributed to the presence of araguspongin C.
Lakshmi
Vijai
V
Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow 226001, India.
Srivastava
Shishir
S
Kumar Mishra
Sunil
S
Misra
Sweta
S
Verma
Meenakshi
M
Misra-Bhattacharya
Shailja
S
D000470:Alkaloids / Q000302:isolation & purification* / Q000494:pharmacology*; D000818:Animals; D017178:Brugia malayi / Q000187:drug effects*; D005368:Filariasis / Q000188:drug therapy; D005369:Filaricides / Q000302:isolation & purification* / Q000494:pharmacology*; D047129:Haliclona / Q000737:chemistry*; D008124:Locomotion / Q000187:drug effects; D023421:Models, Animal; D051189:Murinae / Q000469:parasitology; D011807:Quinolizines / Q000302:isolation & purification* / Q000494:pharmacology*; D016019:Survival Analysis
D000470:Alkaloids; D005369:Filaricides; D011807:Quinolizines; C455173:araguspongine C